Microbix Biosystems Inc, an innovator of biological products and technologies, announced it has commenced a new patent litigation against Novartis, alleging infringement of its VIRUSMAX® patent in Europe

Novartis Sued by Microbix for Flu Vaccine Patent Infringement

Microbix Biosystems announced it has commenced a new patent litigation against Novartis, alleging infringement of its Virusmax patent in Europe The announcement came on July 10th, which detailed that Microbix Biosystems has commenced a new patent litigation in the Court of Dusseldorf, Germany against Novartis Vaccines and Diagnostics, alleging infringement of its VIRUSMAX patent in Europe. This is not the first time …